InsidersTradesSigma
Track the BECTON DICKINSON AND COMPANY share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €50bn. The latest transaction was disclosed on 26 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MICHAEL FELD. All data is accessible without an account.
Analysts rate BECTON DICKINSON AND COMPANY Buy (bullish), based on 12 analysts. Average price target: US$192.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Becton Dickinson and Company es una empresa estadounidense que se especializa en la fabricación de dispositivos médicos, diagnósticos y soluciones de gestión de medicamentos. Cotiza en NASDAQ bajo el símbolo BDX.